Ironwood Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.09M | Sell |
3,355
-16
| -0.5% | -$16.2K | 0.44% | 66 |
|
|
2025
Q4 | $3.62M | Sell |
3,371
-86
| -2% | -$82.2K | 0.51% | 56 |
|
|
2025
Q3 | $2.64M | Sell |
3,457
-85
| -2% | -$63.3K | 0.38% | 69 |
|
|
2025
Q2 | $2.76M | Sell |
3,542
-23
| -0.6% | -$17.9K | 0.43% | 61 |
|
|
2025
Q1 | $2.94M | Buy |
3,565
+88
| +3% | +$73.2K | 0.51% | 56 |
|
|
2024
Q4 | $2.68M | Buy |
3,477
+5
| +0.1% | +$4.14K | 0.46% | 60 |
|
|
2024
Q3 | $3.08M | Sell |
3,472
-8
| -0.2% | -$7.19K | 0.51% | 57 |
|
|
2024
Q2 | $3.15M | Buy |
3,480
+52
| +2% | +$41.6K | 0.56% | 56 |
|
|
2024
Q1 | $2.67M | Buy |
3,428
+1
| +0% | +$712 | 0.47% | 61 |
|
|
2023
Q4 | $2M | Buy |
3,427
+172
| +5% | +$100K | 0.37% | 71 |
|
|
2023
Q3 | $34.3K | Buy |
3,255
+8
| +0.2% | +$4.12K | 0.01% | 243 |
|
|
2023
Q2 | $1.52M | Sell |
3,247
-39
| -1% | -$16.4K | 0.34% | 72 |
|
|
2023
Q1 | $1.13M | Sell |
3,286
-248
| -7% | -$83.6K | 0.27% | 87 |
|
|
2022
Q4 | $1.29M | Sell |
3,534
-5
| -0.1% | -$1.77K | 0.31% | 83 |
|
|
2022
Q3 | $1.14M | Buy |
3,539
+151
| +4% | +$47.8K | 0.33% | 78 |
|
|
2022
Q2 | $1.1M | Sell |
3,388
-103
| -3% | -$30.9K | 0.31% | 80 |
|
|
2022
Q1 | $999K | Sell |
3,491
-75
| -2% | -$19.3K | 0.25% | 91 |
|
|
2021
Q4 | $985K | Hold |
3,566
| – | – | 0.22% | 90 |
|
|
2021
Q3 | $823K | Buy |
3,566
+200
| +6% | +$49.4K | 0.21% | 88 |
|
|
2021
Q2 | $772K | Sell |
3,366
-100
| -3% | -$20.1K | 0.21% | 91 |
|
|
2021
Q1 | $647K | Sell |
3,466
-139
| -4% | -$27.2K | 0.19% | 102 |
|
|
2020
Q4 | $608K | Buy |
3,605
+1,182
| +49% | +$176K | 0.14% | 117 |
|
|
2020
Q3 | $358K | Buy |
2,423
+35
| +1% | +$5.42K | 0.1% | 139 |
|
|
2020
Q2 | $392K | Buy |
2,388
+26
| +1% | +$3.99K | 0.12% | 125 |
|
|
2020
Q1 | $327K | Hold |
2,362
| – | – | 0.13% | 118 |
|
|
2019
Q4 | $310K | Buy |
2,362
+162
| +7% | +$18.8K | 0.11% | 132 |
|
|
2019
Q3 | $246K | Hold |
2,200
| – | – | 0.09% | 149 |
|
|
2019
Q2 | $243K | Hold |
2,200
| – | – | 0.09% | 145 |
|
|
2019
Q1 | $285K | Hold |
2,200
| – | – | 0.11% | 125 |
|
|
2018
Q4 | $254K | Hold |
2,200
| – | – | 0.11% | 125 |
|
|
2018
Q3 | $236K | Buy |
+2,200
| New | +$220K | 0.09% | 140 |
|
|
2017
Q3 | – | Sell |
-7,300
| Closed | -$601K | – | 158 |
|
|
2017
Q2 | $601K | Buy |
7,300
+100
| +1% | +$8.16K | 0.23% | 89 |
|
|
2017
Q1 | $605K | Hold |
7,200
| – | – | 0.25% | 81 |
|
|
2016
Q4 | $530K | Hold |
7,200
| – | – | 0.24% | 83 |
|
|
2016
Q3 | $578K | Hold |
7,200
| – | – | 0.27% | 79 |
|
|
2016
Q2 | $567K | Sell |
7,200
-90
| -1% | -$6.78K | 0.33% | 75 |
|
|
2016
Q1 | $524K | Buy |
7,290
+90
| +1% | +$6.81K | 0.27% | 80 |
|
|
2015
Q4 | $607K | Hold |
7,200
| – | – | 0.35% | 74 |
|
|
2015
Q3 | $602K | Hold |
7,200
| – | – | 0.33% | 76 |
|
|
2015
Q2 | $601K | Sell |
7,200
-3
| -0% | -$229 | 0.31% | 78 |
|
|
2015
Q1 | $523K | Buy |
7,203
+3
| +0% | +$214 | 0.27% | 82 |
|
|
2014
Q4 | $497K | Hold |
7,200
| – | – | 0.25% | 88 |
|
|
2014
Q3 | $467K | Hold |
7,200
| – | – | 0.25% | 86 |
|
|
2014
Q2 | $448K | Hold |
7,200
| – | – | 0.23% | 88 |
|
|
2014
Q1 | $424K | Sell |
7,200
-320
| -4% | -$17.9K | 0.23% | 90 |
|
|
2013
Q4 | $384K | Sell |
7,520
-2,830
| -27% | -$142K | 0.22% | 96 |
|
|
2013
Q3 | $521K | Buy |
10,350
+3,250
| +46% | +$170K | 0.34% | 71 |
|
|
2013
Q2 | $349K | Buy |
+7,100
| New | +$386K | 0.23% | 81 |
|
Other funds holding LLY
VCM
VPM
Ironwood Investment Counsel's LLY Position: Q1 2026 in Review
Ironwood Investment Counsel reduced its Eli Lilly (LLY) stake by 0.47% in Q1 2026, selling an estimated $16.2K and leaving 3,355 shares worth $3.09M. The position accounts for 0.44% of the portfolio, ranked #66.
Ironwood Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.62M in Q4 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Ironwood Investment Counsel held 3,355 shares of Eli Lilly worth $3.09M as of Q1 2026.
- Ironwood Investment Counsel sold 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
- Eli Lilly made up 0.44% of Ironwood Investment Counsel's portfolio in Q1 2026, its #66 holding.
- Ironwood Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
- Ironwood Investment Counsel's Eli Lilly position peaked at $3.62M in Q4 2025.
- 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.